Consonance Capital Partners
Overview
Consonance Capital Partners is a private equity firm that invests exclusively in the U.S. healthcare industry, targeting lower and middle-market companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Embark Healthcare | Sep 2022 | Private Equity | Lead |
| Priority Ambulance | Jul 2022 | Buyout/LBO | Co-investor |
| Priority OnDemand | Oct 2021 | Buyout/LBO | Lead |
| Sugar | Aug 2021 | Seed | Lead |
Key People
Benjamin Edmands
Managing Partner And Co- Founder
Nancy-Ann DeParle
Partner
Michael Zhuang
Principal
Sapna Jethwa
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Consonance Capital Partners based?
Consonance Capital Partners is headquartered in New York City, New York, United States.
When was Consonance Capital Partners founded?
Consonance Capital Partners was founded in 2005.
How many portfolio companies does Consonance Capital Partners have?
Consonance Capital Partners has 4 portfolio companies in Caplight's dataset.
What are some companies in Consonance Capital Partners's portfolio?
Recent investments visible on Caplight include Embark Healthcare, Priority Ambulance, Priority OnDemand, Sugar.
What was Consonance Capital Partners's most recent investment?
Consonance Capital Partners's most recent investment on Caplight was in Embark Healthcare in 2022.
What sectors does Consonance Capital Partners focus on?
Consonance Capital Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Real Estate & PropTech, Healthcare & Life Sciences, Enterprise Software, Mobility, Transportation & Logistics, Mobility, Transportation & Logistics.
What company stages does Consonance Capital Partners focus on?
Stage focus information for Consonance Capital Partners is not publicly available.
What is Consonance Capital Partners's AUM?
Consonance Capital Partners's assets under management are estimated between $1.4B and $2.5B.